Company intelligence / Profile preview
Radiance Biopharma, Inc.
Boston, Massachusetts, United States*volza.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
The company’s lead asset RB-164™ is a next-generation ADC targeting ROR1. It has entered Phase I clinical trials for hematologic and solid malignancies. Preclinical data suggest favorable pharmacokinetics and toxicity profiles. Additional programs are in preclinical development[8][9].
- Therapeutic areas
- OncologyHematology
- Modalities
- Antibody Drug Conjugates (ADCs)Monoclonal antibodies (mAbs)Bispecific antibodies
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
CSPC Megalith Biopharmaceutical Co., Ltd. / CSPC Pharmaceutical Group Limited — exclusive license for RB‑164 in major Western markets[3].Biocytogen Pharmaceuticals — option/license agreement for bispecific anti-HER2/TROP2 BsADC program[10].
Beyond the preview
Go deeper on Radiance Biopharma, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Radiance Biopharma, Inc..